Rankings
▼
Calendar
ARQT FY 2024 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ARQT
Arcutis Biotherapeutics, Inc.
$3B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$197M
+229.7% YoY
Gross Profit
$177M
90.3% margin
Operating Income
-$128M
-65.3% margin
Net Income
-$140M
-71.3% margin
EPS (Diluted)
$-1.16
Cash Flow
Operating Cash Flow
-$112M
Free Cash Flow
-$112M
Stock-Based Comp.
$42M
Balance Sheet
Total Assets
$349M
Total Liabilities
$191M
Stockholders' Equity
$158M
Cash & Equivalents
$71M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$197M
$60M
+229.7%
Gross Profit
$177M
$55M
+224.8%
Operating Income
-$128M
-$241M
+46.7%
Net Income
-$140M
-$262M
+46.6%
← Q4 2023
All Quarters
Q1 2024 →